The Patient Voice & Patient-Focused Drug Development

07/23/2020 12:00

Patient-focused drug development is a systematic approach to help ensure that patients’ experiences, perspectives, needs, and priorities are captured and meaningfully incorporated into clinical testing. This week, you can learn from experts how this new paradigm in drug development is impacting the way researchers and pharma companies think about trials and how it is making healthcare more responsive to the people whose opinions matter the most--patients like you.

Speakers

Samit Hirawat M.D.
Chief Medical Officer, Global Drug Development, Bristol Myers Squibb

View Bio

Danielle Halstrom
Head, R&D, GPS and Commercial Communications & Global Advocacy Corporate Affairs, Bristol Myers Squibb

View Bio

Begonya Nafria
Coordinator, Share4Rare & Patient Engagement in Research Coordinator, Sant Joan de Déu Children's Hospital

View Bio

Kathleen A. Arntsen
President & CEO, Lupus and Allied Diseases Association, Inc.

View Bio

Tamás Bereczky MA, PhD
Courses and Contents Coordinator, EUPATI

View Bio

Oriana Sousa
SCOCHT survivor, Founder/Psychologist, Dealing with Cancer, Patient Advocate, Rare 2030, EUPATI Student

View Bio